Plain-English translation of NCT07400393 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our ALS research guide โThis is a screening study that is the first step toward joining one of several early-stage ALS treatment trials. During screening, researchers will collect information about your health โ including blood samples, heart rhythm tests, and medical history โ to see if you might be eligible for one or more of the new treatments being tested in the ALS MyMatch program. If you qualify, your doctor can help you decide which trial might be the best fit for you.
ALS affects everyone differently, and there is no one-size-fits-all treatment. This screening program exists to help match patients with early-stage treatments that have the best chance of working for their specific situation, so that more people can access experimental therapies that may help them.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will complete a screening visit that can take up to 45 days and includes activities that can be done remotely. During screening, you will provide consent, review your medical history, give blood samples, have a heart rhythm test (ECG), and answer questionnaires. The information collected helps researchers determine if you might be eligible for one or more of the early-stage treatment trials in the ALS MyMatch program. If you qualify for multiple studies, you and your doctor can discuss which trial might be best for you.
AI-generated summary from trial data ยท Nov 17, 2026 ยท Not medical advice
United States